Ventirx Pharmaceuticals
AcquiredSeattle, United States · Founded 2007 · $75.0M raised
- Headquarters
- Seattle
- Founded
- 2007
- Business Model
- B2B
- Total Funding
- $75.0M
- Last Round
- $50.0M Venture RoundSep 2014
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
VentiRx Pharmaceuticals Inc. is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies for the treatment of cancer, respiratory and inflammatory diseases. The company's lead product candidate is motolimod (VTX-2337), a small molecule TLR8 agonist for the treatment of cancer. VentiRx is a privately held organization based in Seattle, Washington.
Summary
Ventirx Pharmaceuticals is a Biotech company based in Seattle, United States, founded in 2007. It has raised $75.0M in total across 2 rounds, most recently a $50.0M Venture Round in Sep 2014. Investors include MedImmune Ventures, ARCH Venture Partners and Domain Associates.
Funding History
Sep 2014
Sign up to see all 2 events
Funding: Extension Round through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ventirx-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/ventirx-pharmaceuticals" alt="Ventirx Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>